PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 199 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,775,000 | +18.5% | 100,534 | +50.5% | 0.02% | +15.4% |
| Q2 2017 | $3,186,000 | +24.4% | 66,800 | +18.9% | 0.01% | +30.0% |
| Q1 2017 | $2,562,000 | +249.5% | 56,190 | +147.4% | 0.01% | +233.3% |
| Q4 2016 | $733,000 | -10.1% | 22,708 | -4.7% | 0.00% | 0.0% |
| Q3 2016 | $815,000 | +1.5% | 23,816 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $803,000 | -36.7% | 23,816 | +0.9% | 0.00% | -50.0% |
| Q1 2016 | $1,269,000 | -51.5% | 23,592 | -30.7% | 0.01% | -45.5% |
| Q4 2015 | $2,616,000 | +4.1% | 34,066 | -44.3% | 0.01% | 0.0% |
| Q3 2015 | $2,512,000 | +50.4% | 61,110 | +158.8% | 0.01% | +57.1% |
| Q2 2015 | $1,670,000 | -47.8% | 23,610 | -34.5% | 0.01% | -46.2% |
| Q1 2015 | $3,202,000 | -23.5% | 36,035 | -23.7% | 0.01% | -27.8% |
| Q4 2014 | $4,188,000 | -19.0% | 47,237 | -11.5% | 0.02% | -18.2% |
| Q3 2014 | $5,170,000 | +4.7% | 53,346 | -0.7% | 0.02% | +10.0% |
| Q2 2014 | $4,937,000 | +54.5% | 53,745 | +17.7% | 0.02% | +33.3% |
| Q1 2014 | $3,196,000 | +160.7% | 45,669 | +114.2% | 0.02% | +200.0% |
| Q4 2013 | $1,226,000 | +16.3% | 21,323 | -2.8% | 0.01% | 0.0% |
| Q3 2013 | $1,054,000 | +114.2% | 21,927 | +29.2% | 0.01% | +66.7% |
| Q2 2013 | $492,000 | – | 16,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |